Status:
COMPLETED
Cerebral Compliance Impairment in COVID-19
Lead Sponsor:
University of Sao Paulo
Conditions:
Intracranial Hypertension
Cerebral Circulatory Failure
Eligibility:
All Genders
1+ years
Brief Summary
Several recent studies point to the possibility of the new coronavirus (SARS-Cov2), which currently causes pandemic COVID-19, to infiltrate the central nervous system (CNS) and cause primary damage to...
Detailed Description
The gravity of the disease caused by the new coronavirus 2019 (COVID-19) is predominantly harbored in severe acute respiratory syndrome (SARS), often requiring ventilatory support. However, in some ca...
Eligibility Criteria
Inclusion
- patients with SARS for COVID-19, under ventilatory support of any age and gender
Exclusion
- the absence of legally authorized responsible (LAR) consent,
- patients without temporal acoustic window for TCD assessment,
- patients unable to undergo monitoring with the NICC sensor due to lesions and/or skin infections in the sensor application region,
- patients with head circumference smaller than 47 cm.
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04429477
Start Date
May 1 2020
End Date
July 31 2020
Last Update
September 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital das Clínicas da Faculdade de Medicina da USP.
São Paulo, Brazil, 05403000